Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Dual-Task Versus Combined Exercise Training in Older Adults With Type 2 Diabetes

torstai 17. syyskuuta 2026 päivittänyt: Gizem Mermerkaya, Bartın Unıversity

Kaksitehtäväharjoittelun vaikutus tasapainoon, harjoituskykyyn, kognitiiviseen tilaan ja elämänlaatuun tyypin 2 diabetesta sairastavilla yksilöillä

The aim of this randomized controlled study is to investigate the effects of dual-task training on functional mobility, exercise capacity, cognitive function, and quality of life in adults aged 65 years and older with type 2 diabetes mellitus. Changes in serum brain-derived neurotrophic factor (BDNF) levels will also be assessed as a secondary outcome.

The study will compare three groups: dual-task training, combined exercise training, and a control group. Both exercise groups will receive aerobic, resistance, and balance training three times per week for eight weeks. In the dual-task group, participants will perform cognitive tasks targeting memory, verbal fluency, executive function, calculation, and attention concurrently with the physical exercises. The combined exercise group will perform the physical exercises without concurrent cognitive tasks.

The main research question is whether adding simultaneous cognitive tasks to combined exercise training provides additional benefits for functional mobility, assessed using the Timed Up and Go test. The study will also examine effects on exercise capacity, cognitive function, dual-task performance, quality of life, and serum BDNF levels. Outcomes will be compared across the three groups.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

Older adults with type 2 diabetes mellitus (T2DM) may experience balance, gait, and cognitive impairments. T2DM is associated with an increased risk of cognitive decline and dementia in older adults. Factors such as insulin resistance, impaired glucose metabolism, advanced glycation end-products, impaired amyloid beta clearance, oxidative stress, and inflammation may contribute to these changes. T2DM has been linked to impairments in episodic memory, verbal fluency, working memory, processing speed, and executive functions. Executive functions are higher-level processes that oversee and regulate other cognitive functions. These capabilities support planning, decision-making, switching between tasks, goal-directed behavior, and coordinating simultaneous activities. Executive function also contributes to the integration of sensory information required for balance and gait. Impairments in these functions may therefore compromise functional mobility and increase fall risk in older adults with T2DM.

Dual-task paradigms are used to examine performance when two tasks are undertaken simultaneously. A primary motor task, such as walking, is combined with a secondary task, and the effects on performance are evaluated. Everyday activities, such as walking while talking, frequently involve these simultaneous demands. When the combined demands of the tasks exceed available attentional resources, performance on one or both tasks may deteriorate. Executive dysfunction may increase this interference. Dual tasks can involve motor-cognitive, cognitive-cognitive, or motor-motor combinations. Previous research has reported adverse effects of dual-task conditions on gait parameters in individuals with T2DM. These findings highlight the importance of considering the interaction between cognitive abilities and motor skills when planning rehabilitation programs.

The effects of dual-task training on balance and cognitive function have been investigated in other populations at increased risk of falls, including stroke survivors, individuals with Parkinson's disease, and older adults with a history of falls. Because cognitive processes contribute to balance and mobility, evaluating physical performance together with cognitive function may provide a more comprehensive understanding of the effects of dual-task training. Previous studies have reported improvements in balance and executive function following dual-task training in older adults. Combined aerobic and resistance exercise has also shown potential benefits for cognition in individuals with T2DM. However, whether adding concurrent cognitive tasks to a combined exercise program provides additional benefits in older adults with T2DM remains unclear.

Brain-derived neurotrophic factor (BDNF) is involved in synaptic plasticity and may provide a biological link between exercise and cognitive function. Nevertheless, reported BDNF responses to exercise in individuals with T2DM have been variable. Assessing serum BDNF alongside functional and cognitive outcomes may help characterize the responses to combined physical and cognitive training, although serum measurements alone cannot establish changes in brain function.

This three-arm randomized controlled study will investigate the effects of dual-task training compared with combined exercise training and a control condition in adults aged 65 years and older with T2DM. Participants will be randomly assigned to the dual-task training group, the combined exercise training group, or the control group. Both exercise groups will undergo aerobic, resistance, and balance training three times per week for eight weeks. The dual-task group will perform the same physical exercise program with concurrent cognitive tasks targeting memory, verbal fluency, executive function, mental arithmetic, and divided attention. The combined exercise group will perform the physical exercises without concurrent cognitive tasks. The control group will receive standardized education on physical activity, glycemic self-monitoring, and reducing sedentary behavior, with weekly telephone contact.

The study will examine whether adding concurrent cognitive tasks to combined exercise training provides additional benefits for functional mobility, assessed using the Timed Up and Go test. Exercise capacity, global cognitive function, executive function, reaction time, dual-task mobility and cost, diabetes-specific quality of life, and serum BDNF levels will also be evaluated before and after the intervention. The study aims to clarify the potential contribution of concurrent cognitive training to rehabilitation in older adults with T2DM.

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

45

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • Bartın
      • Bartın, Bartın, Turkki (Türkiye), 74000
        • Bartın University

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

65 vuotta ja vanhemmat (Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Being followed up with a diagnosis of Type 2 Diabetes Mellitus for at least 6 months (fasting plasma glucose of 7.0 mmol/L or higher)
  • Not having participated in any structured exercise program for at least 6 months prior.
  • Being willing to volunteer for the study

Exclusion Criteria:

  • Nephropathy
  • Retinopathy
  • Having dementia or Alzheimer's disease
  • Using a walking aid
  • Having ulceration
  • Using balance-curing drugs
  • Surviving myocardial infarction at least 6 months ago
  • Stable or unstable angina pectoris
  • Left ventricular ejection fraction below 40%
  • Peripheral arterial diseases
  • Resting blood pressure above 160/100 mmHg
  • Body mass index above 35 kg/m2
  • Having a history of deep vein thrombosis, pulmonary embolism or stroke in the past

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Hoito
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Yksittäinen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: dual task exercise group

Patients in the dual-task training group will undergo 60-75 minute conventional physiotherapy sessions three times a week for 8 weeks. Each physiotherapy session will consist of aerobic exercise, strengthening exercises, and balance training. In addition, cognitive exercise training will be incorporated into each session, performed concurrently with the conventional physiotherapy. The cognitive exercises provided in this study are structured to target areas such as memory, verbal fluency, executive functions, calculation, and attention.

Dual task exercise group Patients in the dual-task training group will undergo 60-75 minute conventional physiotherapy sessions three times a week for 8 weeks. Each physiotherapy session will consist of aerobic exercise, strengthening exercises, and balance training. In addition, cognitive exercise training will be incorporated into each session, performed concurrently with the conventional physiotherapy. The cognitive exercises provided in this study are structured to target areas such as memory, verbal fluency, executive functions, calculation, and attentioN Single task exercise group Patients in the single-task training group will undergo 60-minute conventional physiotherapy sessions three times a week for 8 weeks. Each physiotherapy session will consist of aerobic exercise, strengthening exercises, and balance training.

Active Comparator: Combined Exercise Training Group

Patients in the single-task training group will undergo 60-75 minute conventional physiotherapy sessions three times a week for 8 weeks. Each physiotherapy session will consist of aerobic exercise, strengthening exercises, and balance training.

Combined Exercise Training Group Patients in the single-task training group will undergo 60-75 minute conventional physiotherapy sessions three times a week for 8 weeks. Each physiotherapy session will consist of aerobic exercise, strengthening exercises, and balance training.

Ei väliintuloa: control group

Participants in the control group will be instructed to continue their usual daily activities without participating in a structured exercise training program during the eight-week study period. They will receive standardized education on physical activity, blood glucose self-monitoring, and reducing sedentary behavior, with weekly telephone contact. After the final assessment, participants will be invited to join an exercise training program of their choice.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Time Up and Go Test
Aikaikkuna: Baseline and immediately after the eight-week intervention.

This test is applied to assess the risk of falling and mobility.This test starts with the individual leaving the chair without receiving arm support by giving the go command while sitting in a chair.The distance of 3 meters is asked to return and sit again in the chair.The elapsed time is recorded in seconds.

Baseline and immediately after the eight-week intervention.

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Functional exercise capacity Functional Exercise Capacity
Aikaikkuna: Baseline and immediately after the eight-week intervention.

Functional exercise capacity will be assessed using the 6-Minute Walk Test (6MWT). The participants will be instructed to walk at their maximum comfortable pace for 6 minutes along a 30-meter long, flat, and uninterrupted corridor. At the end of the test, the endpoint will be marked, and the total distance walked will be calculated.

Baseline and immediately after the eight-week intervention.
Timed Up and Go Test (Cognitive)
Aikaikkuna: Baseline and immediately after the eight-week intervention.

Participants will be asked to perform both the single-task and cognitive dual-task versions of the Timed Up and Go (TUG) test. In the single-task condition, participants will complete the TUG test without any secondary task. In the cognitive dual-task condition, participants will perform the TUG test while also engaging in a cognitive task, specifically subtracting 3 from 100 repeatedly during the walk.

Baseline and immediately after the eight-week intervention.
Montreal Cognitive Assessment (MoCA)
Aikaikkuna: Baseline and immediately after the eight-week intervention.

Cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA). The MoCA is a reliable assessment tool that is particularly effective in testing cognitive levels in individuals with mild cognitive impairment and Alzheimer's disease. It is designed to evaluate various cognitive domains, including attention, memory, language, visuospatial abilities, executive functions, and orientation, providing a comprehensive measure of cognitive health. This tool is widely used in clinical settings for early detection and monitoring of cognitive decline.

Baseline and immediately after the eight-week intervention.
Stroop Test
Aikaikkuna: Baseline and immediately after the eight-week intervention.

The Stroop Test is a widely used psychological test to assess cognitive flexibility, selective attention, and the ability to inhibit cognitive interference. The test is based on the Stroop Effect, which refers to the delay in reaction time when the name of a color is written in a different color ink.

Baseline and immediately after the eight-week intervention.
Diabetes-specific Quality of Life Scale (ADDQoL)
Aikaikkuna: Baseline and immediately after the eight-week intervention.

Diabetes-specific quality of life will be assessed using the Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaire. Two global items and the average weighted impact score will be evaluated to assess the perceived impact of diabetes on quality of life.

Baseline and immediately after the eight-week intervention.
Processing Speed
Aikaikkuna: Baseline and immediately after the eight-week intervention.

The processing speed will be evaluated by measuring the reaction time. To measure the reaction time, a FitLight Trainer (Fitlight Sports Corp., Canada) will be used. The FitLight Trainer is primarily used for training purposes and is also suitable for use with older individuals.

Baseline and immediately after the eight-week intervention.
Biochemical Analysis
Aikaikkuna: Baseline and immediately after the eight-week intervention.

Baseline HbA1c levels will be reported to characterize glycemic status. Serum BDNF levels will be assessed before and after the eight-week intervention.

Baseline and immediately after the eight-week intervention.

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Päätutkija: gizem mermerkaya, Bartın Unıversity

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Yleiset julkaisut

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Tiistai 3. joulukuuta 2024

Ensisijainen valmistuminen (Todellinen)

Sunnuntai 30. marraskuuta 2025

Opintojen valmistuminen (Todellinen)

Tiistai 16. joulukuuta 2025

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Tiistai 3. joulukuuta 2024

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Torstai 5. joulukuuta 2024

Ensimmäinen Lähetetty (Todellinen)

Perjantai 6. joulukuuta 2024

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Tiistai 22. syyskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Torstai 17. syyskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa